Lifeward Ltd. Unveils Investor Presentation Showcasing Innovative Rehabilitation Technologies and Path to Profitability
Reuters
May 22
Lifeward Ltd. Unveils Investor Presentation Showcasing Innovative Rehabilitation Technologies and Path to Profitability
Lifeward Ltd., formerly known as ReWalk Robotics, has unveiled its latest investor presentation, highlighting its innovative technologies aimed at transforming the lives of individuals with physical limitations or disabilities. The company has made significant strides with its ReWalk Personal Exoskeleton, which has received both FDA and CE approvals, and the AlterG Anti-Gravity Systems, utilizing NASA-derived Differential Air Pressure technology. Lifeward Ltd. is also expanding its market presence, particularly in the U.S. and Germany, with Medicare coverage in place since April 2024. The company is focusing on securing private insurance coverage to further grow its addressable market. Lifeward Ltd. is on a path to profitability, expecting to reduce operating losses in 2025 and achieve profitability by 2026. The full presentation can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief on May 22, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.